News for Gerresheimer AG (GRRMF)

Stifel has changed its rating on Gerresheimer (GRRMF), lowering it from a Buy to a Hold. The financial services company has set a price target of EUR 55 for the

Berenberg has revised its rating for Gerresheimer (GRRMF), changing it from a Buy to a Hold. Additionally, the firm has lowered its price target significantly f

Barclays analyst Gaurav Jain has revised the price target for Gerresheimer (GRRMF), decreasing it from EUR 80 to EUR 67. Despite this adjustment, the analyst ma

JPMorgan has revised its price target for Gerresheimer (GRRMF), lowering it from EUR 122.50 to EUR 108. Despite this adjustment, the firm maintains an Overweigh

DZ Bank has reevaluated its stance on Gerresheimer (GRRMF), shifting its rating from Buy to Hold. This adjustment accompanies a set price target of EUR 50 for t

Deutsche Bank has adjusted its outlook on Gerresheimer (GRRMF), lowering its rating from Buy to Hold. Alongside this downgrade, the bank has revised the price t

Financial analysts at Bernstein have adjusted their stance on Gerresheimer (GRRMF), downgrading the stock from "Outperform" to "Underperform." The price target

Insights from the First Quarter of 2025 N-PORT Filing Oakmark Intl Small Cap (Trades, Portfolio) recently submitted its N-PORT filing for the first quarter of

Revenue: Increased by 11.6% from EUR466 million in Q1 2024 to EUR520 million in Q1 2025.Adjusted EBITDA: Grew by 13.1% from EUR81 million to nearly EUR92 milli

Apr 11, 2025 / 08:00AM GMTOperator Ladies and gentlemen, welcome to the publication Q1 2025 results conference call. I am George, the chorus call operator. (Ope

Gerresheimer AG (OTCPK:GRRMF) Q1 2025 Earnings Conference Call April 11, 2025 4:00 AM ETCompany ParticipantsGuido Pickert - Vice President, Corporate...

(Bloomberg) -- Donald Trump’s trade war has hit billions of dollars worth of potential mergers, acquisitions and initial public offerings in less than 24 hours. Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersMetro-North Is Faster Than Acela on NYC-New Haven Route After Signal UpdatesLocal Governments Vie for Fired Federal WorkersLondon Clears Final Hurdle for More High-Speed Trains to EuropeWhat Would ‘Transportation Abundance’ Look Like?Ticket platform StubHub Holdin

FRANKFURT/NEW YORK (Reuters) -A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the matter said. The group has submitted a bid at close to 90 euros a share, one of the people said, which would value the company at nearly 3.1 billion euros ($3.37 billion), according to LSEG data, against 2.65 billion euros as of Friday's close. Spokespeople for KKR and Warburg Pincus declined to comment.

(Bloomberg) -- A consortium consisting of Warburg Pincus and KKR & Co. are in talks to acquire Gerresheimer AG, the German maker of packaging for drugs and cosm...

Q4 Organic Revenue Growth: 5.4%Q4 Adjusted EBITDA Growth: 6.4%Q4 Adjusted Earnings Per Share Growth: 6.7%Full Year Organic Revenue Growth: 2.9%Full Year Adjust

Feb 26, 2025 / 09:00AM GMTOperator Ladies and gentlemen, welcome to the publication Q4 and full year 2024 results conference call. I am Vicky, the Chorus Call o

Gerresheimer AG (OTCPK:GRRMF) Q4 2024 Results Conference Call February 26, 2025 4:00 AM ETCompany ParticipantsGuido Pickert - Investor RelationsDietmar...

Germany stocks mixed at close of trade; DAX up 0.24%

Germany stocks higher at close of trade; DAX up 0.49%